New malaria vaccine reduces death rates

On July 5, Director-General of the World Health Organization (WHO) Tedros Ghebreyesus announced that the RTS,S malaria vaccine developed by British pharmaceutical company GSK is a "safe and effective" vaccine that helps "significantly reduce acute malaria."

Health workers prepare to administer malaria vaccinations to children in Yala, Kenya.

According to a VNA correspondent in Africa, speaking at a press conference, the WHO Director-General stated that RTS,S is the first vaccine to prevent malaria. He stressed that malaria remains one of the most deadly diseases in Africa. Nearly 500,000 children under the age of 5 on the continent die from malaria each year. The RTS,S vaccine has been provided to more than 1.6 million children in Ghana, Kenya and Malawi under a pilot program.

However, WHO Director of Immunisation, Vaccines and Biologicals Katherine O'Brien warned that despite the "new tool", it was important to remember that almost every minute a child dies from malaria. "I think it's really important to remember that almost every minute a child dies from malaria, and introducing a malaria vaccine as an additional tool in the toolbox to fight serious disease and prevent deaths is a really necessary step," she stressed.

According to United Nations studies, climate change is increasing the number of mosquitoes that carry malaria-like diseases.

(According to Vietnam+)

Patient D. was taken to the emergency room by his family in a state of fever, septic shock, pale skin and mucous membranes, sweating, and abdominal pain.

At 10:00 a.m. on July 12, Luc Yen District Medical Center received male patient HVD, 18 years old. The patient had intellectual disability and was hospitalized with fever, septic shock, pale skin and mucous membranes, sweating, and abdominal pain.

People come to register for medical examination and treatment at medical facilities.

The Ministry of Health has just issued Circular No. 13 regulating the price framework and pricing methods for medical examination and treatment services on demand at public health facilities. The Circular is considered to "open the way" for medical facilities to operate as well as provide specific instructions for units to have a basis for building service prices in a unified manner.

In addition to hospitalization for dengue fever cases at warning and severe levels, according to the new guidelines of the Ministry of Health, when dengue fever is at level 1, there are 8 cases that are also considered for hospitalization.

Yen Bai Provincial Medical Association headquarters is located at the Department of Health.

Yen Bai Provincial Medical Association was established on the basis of merging 3 associations: Public Health Association, Medical and Pharmaceutical Association, Family Planning Association from July 1, 2023.

Source link